DENVER, March 11, 2019 /PRNewswire/ — Helix TCS, Inc. (OTCQB: HLIX) (the “Company”), through its leading seed to sale and cannabis point of sale subsidiary, BioTrackTHC, has been awarded a 2-year contract extension with the State of Delaware to continue providing the state’s medical cannabis traceability system through April 30, 2021. BioTrackTHC was awarded the Delaware traceability contract in May of 2017 and currently operates 9 government cannabis tracking systems across 7 states, Puerto Rico, and the city of Arcata, California.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.